As a pay-for-delay case continues in the nation’s Supreme Court, a lobby for independent drugstores is reportedly seeking widespread exemptions from antitrust laws that would allow the drugstores to charge higher prices for prescription drugs. The Pharmaceutical Care Management Association announced the news last Friday. Those lobby has sought the exemptions, which would affect consumers, employees, unions and government agencies, in the past. A recent government report found 80 percent of independent drugstores hire Pharmacy Service Administrative Organizations to do contract negotiations for them. The PMCA is voicing its opposition to the lobby’s requests arguing that they are asking for permission to fix prices and will lead in dramatic price hikes.
Featured News
Age-Restriction Laws Are Proliferating; So Too Are the Difficult Tradeoffs Policymakers Face
Dec 23, 2025 by
CPI
Federal AI Strategy Raises Compliance Stakes for Banks and Big Tech
Dec 23, 2025 by
CPI
Google Sues Alleged China-Based Hackers Over Widespread Phishing Scheme
Dec 22, 2025 by
CPI
Europe Moves to Clarify What Counts as Personal Data
Dec 22, 2025 by
CPI
Larry Ellison Offers $40 Billion Guarantee as Paramount Renews Bid for Warner Bros
Dec 22, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi